UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Recovery of bovine lysozyme from transgenic sugarcane stalks: extraction, membrane filtration, and purification

Bioprocess and biosystems engineering, 2013-10, Vol.36 (10), p.1407-1416

2013

Volltextzugriff (PDF)

Mast cells' involvement in inflammation pathways linked to depression: evidence in mastocytosis

Molecular psychiatry, 2016-11, Vol.21 (11), p.1511-1516

2016

Volltextzugriff (PDF)

Nicotine dependence and reward differ between adolescent and adult male mice

The Journal of pharmacology and experimental therapeutics, 2007-07, Vol.322 (1), p.399-407

2007

Volltextzugriff (PDF)

Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs

The Journal of pharmacology and experimental therapeutics, 2008-04, Vol.325 (1), p.302-312

2008

Volltextzugriff (PDF)

Subcutaneous Rituximab-MiniCHOP Compared With Subcutaneous Rituximab-MiniCHOP Plus Lenalidomide in Diffuse Large B-Cell Lymphoma for Patients Age 80 Years or Older

Journal of clinical oncology, 2021-04, Vol.39 (11), p.1203-1213

2021

Volltextzugriff (PDF)

N-Oleoyl-glycine reduces nicotine reward and withdrawal in mice

Neuropharmacology, 2019-04, Vol.148, p.320-331

2019

Volltextzugriff (PDF)

Bupropion is a nicotinic antagonist

The Journal of pharmacology and experimental therapeutics, 2000-10, Vol.295 (1), p.321

2000

Volltextzugriff (PDF)

Enantioselective Effects of Hydroxy Metabolites of Bupropion on Behavior and on Function of Monoamine Transporters and Nicotinic Receptors

Molecular pharmacology, 2004-09, Vol.66 (3), p.675-682

2004

Volltextzugriff (PDF)

Characterization of spontaneous and precipitated nicotine withdrawal in the mouse

The Journal of pharmacology and experimental therapeutics, 2003-11, Vol.307 (2), p.526-534

2003

Volltextzugriff (PDF)

Examination of the metabolite hydroxybupropion in the reinforcing and aversive stimulus effects of nicotine in rats

Psychopharmacology, 2015-08, Vol.232 (15), p.2763-2771

2015

Volltextzugriff (PDF)

High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial

Leukemia, 2014-12, Vol.28 (12), p.2367-2375

2014

Volltextzugriff (PDF)

Nicotine place preference in the mouse: influences of prior handling, dose and strain and attenuation by nicotinic receptor antagonists

Psychopharmacology, 2006-02, Vol.184 (3-4), p.456-463

2006

Volltextzugriff (PDF)

Targeting Peroxisome Proliferator-Activated Receptor-α (PPAR- α) to reduce paclitaxel-induced peripheral neuropathy

Brain, behavior, and immunity, 2021-03, Vol.93, p.172-185

2021

Volltextzugriff (PDF)

Inhibition of monoacylglycerol lipase reduces nicotine withdrawal

British journal of pharmacology, 2015-02, Vol.172 (3), p.869-882

2015

Volltextzugriff (PDF)

The histidine triad nucleotide binding 1 protein is involved in nicotine reward and physical nicotine withdrawal in mice

Neuroscience letters, 2013-08, Vol.550, p.129-133

2013

Volltextzugriff (PDF)

Functional interaction between Lypd6 and nicotinic acetylcholine receptors

Journal of neurochemistry, 2016-09, Vol.138 (6), p.806-820

2016

Volltextzugriff (PDF)

Age-dependent differences in nicotine reward and withdrawal in female mice

Psychopharmacologia, 2008-06, Vol.198 (2), p.201-210

2008

Volltextzugriff (PDF)

The nicotinic α6 subunit gene determines variability in chronic pain sensitivity via cross-inhibition of P2X2/3 receptors

Science translational medicine, 2015-05, Vol.7 (287), p.287ra72

2015

Volltextzugriff (PDF)

Optimal use of bendamustine in hematologic disorders: Treatment recommendations from an international consensus panel - an update

Leukemia & lymphoma, 2016-04, Vol.57 (4), p.766-782

2016

Volltextzugriff (PDF)

The endogenous cannabinoid system modulates nicotine reward and dependence

The Journal of pharmacology and experimental therapeutics, 2008-08, Vol.326 (2), p.483-492

2008

Volltextzugriff (PDF)

The β3 subunit of the nicotinic acetylcholine receptor is required for nicotine withdrawal-induced affective but not physical signs or nicotine reward in mice

Pharmacology, biochemistry and behavior, 2019-08, Vol.183, p.1-5

2019

Volltextzugriff (PDF)

Deficit in voluntary wheel running in chronic inflammatory and neuropathic pain models in mice: Impact of sex and genotype

Behavioural brain research, 2021-02, Vol.399, p.113009-113009, Article 113009

2021

Volltextzugriff (PDF)

Diacylglycerol lipase β inhibition reverses nociceptive behaviour in mouse models of inflammatory and neuropathic pain

British journal of pharmacology, 2016-05, Vol.173 (10), p.1678-1692

2016

Volltextzugriff (PDF)

1 – 25 von 183

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(177)
Mit Volltextzugriff
(155)

Publikationsform

Artikel
(182)
Berichte
(1)

Sprache

Englisch
(174)
Französisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Recovery of bovine lysozyme from transgenic sugarcane stalks: extraction, membrane filtration, and purification

Mast cells' involvement in inflammation pathways linked to depression: evidence in mastocytosis

Nicotine dependence and reward differ between adolescent and adult male mice

Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs

Subcutaneous Rituximab-MiniCHOP Compared With Subcutaneous Rituximab-MiniCHOP Plus Lenalidomide in Diffuse Large B-Cell Lymphoma for Patients Age 80 Years or Older

N-Oleoyl-glycine reduces nicotine reward and withdrawal in mice

Bupropion is a nicotinic antagonist

Enantioselective Effects of Hydroxy Metabolites of Bupropion on Behavior and on Function of Monoamine Transporters and Nicotinic Receptors

Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study

Characterization of spontaneous and precipitated nicotine withdrawal in the mouse

Examination of the metabolite hydroxybupropion in the reinforcing and aversive stimulus effects of nicotine in rats

High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial

Nicotine place preference in the mouse: influences of prior handling, dose and strain and attenuation by nicotinic receptor antagonists

Targeting Peroxisome Proliferator-Activated Receptor-α (PPAR- α) to reduce paclitaxel-induced peripheral neuropathy

Inhibition of monoacylglycerol lipase reduces nicotine withdrawal

The histidine triad nucleotide binding 1 protein is involved in nicotine reward and physical nicotine withdrawal in mice

Functional interaction between Lypd6 and nicotinic acetylcholine receptors

Age-dependent differences in nicotine reward and withdrawal in female mice

The nicotinic α6 subunit gene determines variability in chronic pain sensitivity via cross-inhibition of P2X2/3 receptors

Optimal use of bendamustine in hematologic disorders: Treatment recommendations from an international consensus panel - an update

The endogenous cannabinoid system modulates nicotine reward and dependence

The β3 subunit of the nicotinic acetylcholine receptor is required for nicotine withdrawal-induced affective but not physical signs or nicotine reward in mice

Deficit in voluntary wheel running in chronic inflammatory and neuropathic pain models in mice: Impact of sex and genotype

Diacylglycerol lipase β inhibition reverses nociceptive behaviour in mouse models of inflammatory and neuropathic pain

Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study

Suchergebnisse filtern